Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RehabiliTech was a medical technology company focused on developing assistive communication and rehabilitation devices for individuals with severe motor impairments. The company's flagship product, I-TRAX, was a head-mounted eye-tracking system that allowed users to control a computer cursor and communicate through eye movements. Founded as a spin-off from the University of Washington, RehabiliTech targeted patients suffering from conditions such as ALS, stroke, and spinal cord injuries. The company was eventually acquired by DynaVox (now Tobii Dynavox), a leader in the augmentative and alternative communication (AAC) market, to integrate its eye-tracking technology into broader assistive platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RehabiliTech.